Andrew Callos, EVP, Chief Commercial Officer at CYTOKINETICS INC (CYTK), sold 15,000 shares at $85.80 ($1.3M) on 2026-07-01, disclosed to the SEC on 2026-07-02.
Open-market sale of $1.3M CYTK by EVP, Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| CYTK | SELL | 2026-06-01 | $1.1M | — | Filing → |
| CYTK | SELL | 2026-05-05 | $875K | — | Filing → |
| CYTK | SELL | 2026-05-04 | $1.0M | — | Filing → |